Found: 91
Select item for more details and to access through your institution.
Staging Accuracy and Prognostic Value of Prostate-Specific Membrane Antigen PET/CT Strongly Depends on Lymph Node Tumor Burden.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 21, p. 6534, doi. 10.3390/jcm13216534
- By:
- Publication type:
- Article
Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml).
- Published in:
- Prostate, 2001, v. 47, n. 4, p. 252, doi. 10.1002/pros.1069
- By:
- Publication type:
- Article
Defining the window of opportunity in screening for prostate cancer: Validation of a predictive tumor classification model.
- Published in:
- Prostate, 2001, v. 46, n. 2, p. 154, doi. 10.1002/1097-0045(20010201)46:2<154::AID-PROS1019>3.0.CO;2-1
- By:
- Publication type:
- Article
A standardized method to measure the membranous urethral length (MUL) on MRI of the prostate with high inter- and intra-observer agreement.
- Published in:
- European Radiology, 2023, v. 33, n. 5, p. 3295, doi. 10.1007/s00330-022-09320-2
- By:
- Publication type:
- Article
Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12 , 410.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.
- Published in:
- BJU International, 2012, v. 110, n. 8, p. 1169, doi. 10.1111/j.1464-410X.2012.10996.x
- By:
- Publication type:
- Article
Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
- Published in:
- BJU International, 2012, v. 109, n. 2, p. 183, doi. 10.1111/j.1464-410X.2011.10652.x
- By:
- Publication type:
- Article
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
- Published in:
- BJU International, 2012, v. 109, n. 2, p. 176, doi. 10.1111/j.1464-410X.2011.10651.x
- By:
- Publication type:
- Article
Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase.
- Published in:
- BJU International, 2009, v. 104, n. 9, p. 1191, doi. 10.1111/j.1464-410X.2009.08743.x
- By:
- Publication type:
- Article
Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
- Published in:
- BJU International, 2009, v. 104, n. 4, p. 438, doi. 10.1111/j.1464-410X.2009.08695.x
- By:
- Publication type:
- Article
Added Clinical Value of <sup>18</sup>F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 3, p. 342, doi. 10.1016/j.clgc.2023.02.004
- By:
- Publication type:
- Article
3D-Reconstructed Contact Surface Area and Tumour Volume on Magnetic Resonance Imaging Improve the Prediction of Extraprostatic Extension of Prostate Cancer.
- Published in:
- Journal of Digital Imaging, 2023, v. 36, n. 2, p. 486, doi. 10.1007/s10278-022-00756-y
- By:
- Publication type:
- Article
Optimization and validation of <sup>18</sup>F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0293672
- By:
- Publication type:
- Article
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The intra- and interobserver variability of PSMA-expression scores in patients with primary prostate cancer.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01152-z
- By:
- Publication type:
- Article
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation.
- Published in:
- Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01240-8
- By:
- Publication type:
- Article
Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 16, p. 1153, doi. 10.1093/jnci/93.15.1153
- By:
- Publication type:
- Article
Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 15, p. 1153, doi. 10.1093/jnci/93.15.1153
- By:
- Publication type:
- Article
Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2962, doi. 10.3390/cancers15112962
- By:
- Publication type:
- Article
Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1169, doi. 10.3390/cancers14051169
- By:
- Publication type:
- Article
Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 953, doi. 10.3390/cancers11070953
- By:
- Publication type:
- Article
Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case–control matching study.
- Published in:
- International Urology & Nephrology, 2022, v. 54, n. 12, p. 3145, doi. 10.1007/s11255-022-03339-6
- By:
- Publication type:
- Article
Clinical verification of <sup>18</sup>F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0239414
- By:
- Publication type:
- Article
Metastatic disease of screen-detected prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 12, p. 2779, doi. 10.1002/cncr.22374
- By:
- Publication type:
- Article
The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Selection of patients for nerve sparing surgery in robot‐assisted radical prostatectomy.
- Published in:
- BJUI Compass, 2022, v. 3, n. 1, p. 6, doi. 10.1002/bco2.115
- By:
- Publication type:
- Article
Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator.
- Published in:
- Therapeutic Advances in Urology, 2022, v. 14, p. 1, doi. 10.1177/17562872221088536
- By:
- Publication type:
- Article
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Staging prostate cancer.
- Published in:
- Microscopy Research & Technique, 2000, v. 51, n. 5, p. 423, doi. 10.1002/1097-0029(20001201)51:5<423::AID-JEMT4>3.0.CO;2-4
- By:
- Publication type:
- Article
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267260
- By:
- Publication type:
- Article
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 888, doi. 10.2967/jnumed.123.267260
- By:
- Publication type:
- Article
The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1238, doi. 10.2967/jnumed.122.265205
- By:
- Publication type:
- Article
Reproducibility of PSMA PET/CT imaging for primary staging of treatment-naïve prostate cancer patients depends on the applied radiotracer: a retrospective study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263139
- By:
- Publication type:
- Article
Reproducibility of PSMA PET/CT imaging for primary staging of treatment-naïve prostate cancer patients depends on the applied radiotracer: a retrospective study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263139
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.252528
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.252528
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Repeatability of Quantitative<sup> 18</sup>F‐DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F‐DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F‐DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article